CO2 laser therapy for laryngeal and tracheal lesion by the endoscope with the forceps channel

CO2 laser therapy for laryngeal and tracheal lesion by the endoscope with the forceps channel - CO2 laser therapy by the endoscope with the forceps channel

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017698

Enrollment

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A larynx and trachea and pharyngeal inflammatory disorder, neoplastic disease

Interventions

CO2 laser therapy using FiberLaseTM via the endoscope with the forceps channel made in Lumenis.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with the inflammatory and neoplastic disease in larynx and trachea and the pharynx

Exclusion criteria

Exclusion criteria: The cases that enough faucial reflex loss can't be obtained by local anesthesia.

Design outcomes

Primary

Measure	Time frame
Treatment successful execution rate	—

Secondary

Measure	Time frame
Evaluation of the pain by Visual analog scale	—

Countries

Japan

Contacts

Public ContactMasakazu Ikeda

Fukushima Medical University Departmetnt of Otolaryngology

masakazu@fmu.ac.jp024-547-1321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026